Design Therapeutics, Inc.DSGNNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank83
3Y CAGR+2.3%
5Y CAGR+52.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+2.3%/yr
Annual compound
5Y CAGR
+52.1%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
8.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$20.34M+12.8%
2024$18.03M-14.6%
2023$21.13M+11.3%
2022$18.98M+71.7%
2021$11.05M+342.8%
2020$2.50M+129.4%
2019$1.09M-